Established in 2021, Qingdao Anouve Biological Medical Technology Co. ,Ltd. is a scientific and innovative enterprise engaged in the research, development, production and sales of in vitro diagnostic reagents and supporting instruments. The products involve the auxiliary diagnosis, concomitant diagnosis and postoperative monitoring of tumor methylation; Detection of pathogenic nucleic acids such as helicobacter pylori and drug-resistant mutations; Guidance on accurate medication of inflammatory bowel disease; Automatic nucleic acid automatic nucleic acid sample pretreatment system, etc.

The highest goal of the company is to meet the needs of patients. Adhering to the value concept of diligence and pragmatism, we will lead the high-quality development of enterprises through innovation drive and provide better tools and technical support for medical workers through continuous R&D investment and technological innovation to better serve the health of patients. The company will make positive contributions to the cause of human health.